We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCM
9976
CALL
Cheetah Mobile
CMCM
$89.5M
$118K ﹤0.01%
13,080
+4,280
+49% +$42.6K
CMPOW
9977
DELISTED
CompoSecure Inc Warrant
CMPOW
$118K ﹤0.01%
+100,000
New +$91K
PBPB
9978
CALL
DELISTED
Potbelly
PBPB
$118K ﹤0.01%
26,800
-11,600
-30% -$49.1K
RAIL icon
9979
CALL
FreightCar America
RAIL
$270M
$118K ﹤0.01%
+48,900
New +$107K
QNTM
9980
CALL
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$19.5M
$118K ﹤0.01%
1,154
+460
+66% +$54.3K
PRTY
9981
DELISTED
Party City Holdco Inc.
PRTY
$118K ﹤0.01%
+19,135
New +$74.4K
SMED
9982
DELISTED
Sharps Compliance Corp
SMED
$118K ﹤0.01%
+12,475
New +$95.4K
PTRAW
9983
DELISTED
Proterra Inc. Warrant
PTRAW
$118K ﹤0.01%
+50,000
New +$88.8K
KIN
9984
CALL
DELISTED
Kindred Biosciences, Inc.
KIN
$118K ﹤0.01%
27,300
-1,000
-4% -$4.07K
ARAY icon
9985
PUT
Accuray
ARAY
$32.2M
$117K ﹤0.01%
+28,100
New +$103K
DHC
9986
PUT
Diversified Healthcare Trust
DHC
$2.13B
$117K ﹤0.01%
28,500
+3,300
+13% +$13K
LODE icon
9987
Comstock
LODE
$229M
$117K ﹤0.01%
11,290
+7,117
+171% +$74.5K
AIFC
9988
AI Financial Corp
AIFC
$59M
$117K ﹤0.01%
+24,024
New +$102K
CHS
9989
DELISTED
Chicos FAS, Inc.
CHS
$117K ﹤0.01%
73,800
+16,976
+30% +$23.6K
GLEO.U
9990
DELISTED
Galileo Acquisition Corp. Units, each consisting of one Ordinary Share and one Redeemable Warrant
GLEO.U
$117K ﹤0.01%
10,759
-311
-3% -$3.29K
CHMA
9991
PUT
DELISTED
Chiasma, Inc. Common Stock
CHMA
$117K ﹤0.01%
27,000
+9,600
+55% +$40K
QEP
9992
DELISTED
QEP RESOURCES, INC.
QEP
$117K ﹤0.01%
49,039
-18,273
-27% -$27K
GALT icon
9993
CALL
Galectin Therapeutics
GALT
$200M
$116K ﹤0.01%
51,900
+10,700
+26% +$28.1K
TK icon
9994
PUT
Teekay
TK
$1.03B
$116K ﹤0.01%
54,100
-65,500
-55% -$147K
YI
9995
111 Inc
YI
$31.8M
$116K ﹤0.01%
+1,669
New +$113K
CMRX
9996
DELISTED
Chimerix, Inc.
CMRX
$116K ﹤0.01%
24,076
+13,325
+124% +$48.3K
MNRL
9997
PUT
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$116K ﹤0.01%
+10,600
New +$109K
OTIC
9998
PUT
DELISTED
Otonomy, Inc.
OTIC
$116K ﹤0.01%
+17,900
New +$81.3K
BXRX
9999
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$116K ﹤0.01%
82
+75
+1,071% +$153K
RRC icon
10000
Range Resources
RRC
$9.43B
$115K ﹤0.01%
17,201
-1,224,841
-99% -$9M

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.